Borscha Azmi

Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study

Madhumita Shrotri, Maria Krutikov, Tom Palmer et al. · The Lancet Infectious Diseases · 2021 · 193 citations · Full text

Veterinary Medicine, Geriatric Medicine, Infectious Diseases +17

Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England

Maria Krutikov, Tom Palmer, Gokhan Tut et al. · The Lancet Healthy Longevity · 2021 · 128 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study

Gokhan Tut, Tara Lancaster, Maria Krutikov et al. · The Lancet Healthy Longevity · 2021 · 52 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study.

Maria Krutikov, Oliver Stirrup, Hadjer Nacer-Laidi et al. · Northumbria Research Link (Northumbria University) · 2022 · 48 citations · Full text

Public Health, Health Sciences, Infectious Diseases +16

Duration of vaccine effectiveness against SARS-CoV-2 infection, hospitalisation, and death in residents and staff of long-term care facilities in England (VIVALDI): a prospective cohort study

Madhumita Shrotri, Maria Krutikov, Hadjer Nacer-Laidi et al. · The Lancet Healthy Longevity · 2022 · 36 citations · Full text

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +17